Symrise (FRA:SY1) Given a €113.00 Price Target by Barclays Analysts

Barclays set a €113.00 ($118.95) target price on Symrise (FRA:SY1Get Rating) in a research report sent to investors on Monday morning, Borsen Zeitung reports.

Other equities research analysts also recently issued research reports about the company. Deutsche Bank Rese… set a €138.00 ($145.26) target price on Symrise in a research report on Thursday, May 26th. Baader Bank set a €115.00 ($121.05) target price on Symrise in a research report on Monday, May 16th. Sanford C. Bernstein set a €108.00 ($113.68) price target on shares of Symrise in a report on Tuesday, June 14th. Credit Suisse Group set a €117.00 ($123.16) price target on shares of Symrise in a report on Wednesday, March 9th. Finally, UBS Group set a €130.00 ($136.84) price target on shares of Symrise in a report on Thursday, April 28th.

FRA:SY1 opened at €101.90 ($107.26) on Monday. The stock’s fifty day moving average price is €104.09 and its two-hundred day moving average price is €109.91. Symrise has a 1 year low of €56.96 ($59.96) and a 1 year high of €73.48 ($77.35).

Symrise Company Profile (Get Rating)

Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients. It operates through two segments, Taste, Nutrition & Health, and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and flavor solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for aqua feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.

Further Reading

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.